3 Results for "

UGT2B4

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "UGT2B4" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-RS15440
Research Areas:  

Others

UGT2B4 Human Pre-designed siRNA Set A contains three designed siRNAs for UGT2B4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-E72116
Target:  

UGT

Human UGT2B4 is a UDP-glucuronosyltransferase. UGT2B4 catalyzes the glucuronidation of bile acids, Carvedilol (HY-B0006) and 6-hydroxylated bile acids to form glucuronide derivatives. UGT2B4 participates in the inactivation of endogenous and exogenous substances, including catechol estrogens, C19 steroids, phenols and monoterpenoids. Human UGT2B4 can be used in the research of hypertension, angina pectoris, chronic heart failure and intrahepatic cholestasis .
loading...
    loading...
Cat. No.: HY-130046
CAS No.: 547-81-9
Purity:  99.04%
Synonyms: 16-epi-Estriol; 16β,17β-Estriol
Target:  

UGT Bacterial

Research Areas:  

Infection Inflammation/Immunology

16-Epiestriol (16-epi-Estriol; 16β,17β-Estriol) is a natural stereoisomer of estriol and an anti-inflammatory agent that targets UGT. The Ki values of 16-Epiestriol against human UGT1A10 and UGT2B7 are 98.1 μM and 162 μM, respectively. As a glucuronidation substrate, 16-Epiestriol can be modified at the 3-OH, 16-OH and 17-OH sites by various UGT enzymes; in liver microsomes, the modification mainly occurs at the 16-OH and 17-OH sites, while reactions take place at all three sites in intestinal microsomes. 16-Epiestriol acts on the phase II inflammatory process by blocking edema mediated by prostaglandins and leukocyte infiltration. It lacks glycogenic activity or any effect on blood glucose levels, and serves as an important candidate molecule in the research of inflammatory diseases .
loading...
    loading...